Case Study

India Prostate Cancer MRI Diagnostic Market Intelligence

Nationwide primary research across Indian states, hospitals, and diagnostic centers to map MRI capacity, utilization, and oncology demand patterns for strategic healthcare planning.

01Objective

Objective: Understanding State-level Diagnostic Demand and Price Comparsion

A healthcare company required a structured assessment of India’s prostate cancer MRI diagnostic market to support expansion planning and investment evaluation across diagnostic networks. Existing information on imaging demand was fragmented, with limited integration between epidemiology, infrastructure availability, pricing structures, and provider distribution. The client needed a framework capable of explaining both the growth trajectory of prostate cancer diagnostics and the regional disparities in pricing shaping MRI demand across Indian states.
02Objective

Engagement Objectives

The engagement focused on building a decision-ready intelligence framework rather than simple market size estimates. Key objectives included:

  • Develop state-level estimates of prostate cancer MRI diagnostic demand
  • Map diagnostic infrastructure and key MRI centers across major states
  • Benchmark pricing structures and referral patterns across providers
  • Link epidemiology trends with diagnostic capacity to model future demand
  • Provide a reusable framework for evaluating expansion opportunities and partnerships
03Approach

Our Approach

01
Nationwide Primary Data Collection
Conducted structured outreach across diagnostic centers and hospitals in multiple Indian states in local languages to collect data on scan volumes, pricing, referral patterns, and infrastructure availability. The process required adapting engagement methods across states due to differences in access, reporting practices, and language.
02
Infrastructure & Provider Mapping
Validated responses using secondary epidemiology data, provider disclosures, and regional healthcare indicators to ensure consistency between reported utilization and expected diagnostic demand.
03
Epidemiology-Linked Modelling Framework
Combined primary findings with cancer registry trends, state-level healthcare data and demographic projections to build a state-level model capable of explaining both current diagnostic volumes while mapping future demand.
04Insights

Key Insights Delivered

01

Market Structure

Demand growth was closely tied to rising cancer incidence and improvements in early detection awareness, rather than purely to technology expansion. This highlighted the importance of demographic and epidemiological drivers in shaping future diagnostic volumes.
02

Regional Disparities

Large states exhibited significantly higher diagnostic utilization due to infrastructure density and specialist availability, while emerging states showed latent demand constrained by limited imaging capacity.
03

Provider Economics

Pricing structures varied widely across diagnostic centers, with referral patterns from specialists playing a key role in determining scan volumes and revenue stability.
04

Strategic Implications

The integrated model allowed the client to identify priority states for expansion, assess partnership opportunities with diagnostic chains, and evaluate long-term investment viability based on epidemiology-linked demand growth.
05

Ourcome for the client

The resulting framework enabled the client to transition from a national-level view of the imaging market to a granular, state-level understanding of diagnostic demand and pricing structure. It provided a basis for evaluating expansion locations, prioritizing diagnostic partnerships, and aligning investment decisions with states showing the strongest combination of incidence growth and infrastructure readiness.
Report

Related Report

Indian Prostate Cancer MRI Diagnostic Market Size, Share, Opportunities, And Trends By Technique (T1WI, T2WI, Others), By End-User (Hospitals, Diagnostic Laboratories), By Cancer Type (Adenocarcinoma, Transitional cell carcinoma, Others), And By State - Forecasts From 2023 To 2028